792 related articles for article (PubMed ID: 20220182)
1. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
[TBL] [Abstract][Full Text] [Related]
2. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
[TBL] [Abstract][Full Text] [Related]
3. The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients.
Procházka V; Papajík T; Dýšková T; Dihel M; Brychtová S; Prouzová Z; Kriegová E; Lukášová M; Hanáčková V
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):e573-e580. PubMed ID: 31377208
[TBL] [Abstract][Full Text] [Related]
4. Toward a personalized treatment of Hodgkin's disease.
DeVita VT; Costa J
N Engl J Med; 2010 Mar; 362(10):942-3. PubMed ID: 20220189
[No Abstract] [Full Text] [Related]
5. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract][Full Text] [Related]
6. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
10. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
13. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
16. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.
Sánchez-Espiridión B; Martin-Moreno AM; Montalbán C; Medeiros LJ; Vega F; Younes A; Piris MA; Garcia JF
Haematologica; 2012 Jul; 97(7):1080-4. PubMed ID: 22315492
[TBL] [Abstract][Full Text] [Related]
18. Macrophages in Hodgkin's lymphoma.
Pazianas M
N Engl J Med; 2010 Jun; 362(22):2135; author reply 2136. PubMed ID: 20527079
[No Abstract] [Full Text] [Related]
19. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
[TBL] [Abstract][Full Text] [Related]
20. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
